findmyKOL
Clinical trialNCT06506903Active, not recruitingInterventional

Avalus Ultra Post-Approval Study (PAS)

SponsorMedtronic Cardiac SurgeryEnrollment190Aortic Valve Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Hartford Hospital

    Hartford, Connecticut, United States

  • University of Florida Shands

    Gainesville, Florida, United States

  • Emory Saint Joseph'S

    Atlanta, Georgia, United States

  • Wellstar Kennestone Hospital

    Marietta, Georgia, United States

  • Northwestern Memorial Hospital

    Chicago, Illinois, United States

  • University of Michigan Health System - University Hospital

    Ann Arbor, Michigan, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • St. Joseph'S Hospital Health Center

    Syracuse, New York, United States

  • Uh Cleveland Medical Center

    Cleveland, Ohio, United States

  • Promedica Toledo Hospital

    Toledo, Ohio, United States

  • Upmc Presbyterian

    Pittsburgh, Pennsylvania, United States

  • Heart Hospital of Austin

    Austin, Texas, United States

  • Chi Saint Lukes Health - Baylor Saint Lukes Medical Center

    Houston, Texas, United States

  • Houston Methodist Hospital

    Houston, Texas, United States

  • Swedish Medical Center Cherry Hill

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Nov 2024
Primary completion
30 Nov 2026
Completion
30 Nov 2026
Last update posted
21 Apr 2026
Registered enrollment
190
Registry id
NCT06506903

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.